Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Tempest Therapeutics, Inc. (TPST) had Weighted-Average Shares Outstanding (Diluted) of 4.15M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-26.26M |
|
-- |
|
-- |
|
$26.57M |
|
$-26.57M |
|
$0.31M |
|
$-26.26M |
|
$-26.26M |
|
$-26.26M |
|
$-26.26M |
|
$-26.26M |
|
$-26.26M |
|
$-26.57M |
|
$-26.31M |
|
4.15M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
4.15M |
$-6.33 |
|
$-6.33 |
|
| Balance Sheet Financials | |
$8.27M |
|
$0.60M |
|
$8.66M |
|
$16.93M |
|
$3.31M |
|
-- |
|
$6.95M |
|
$10.26M |
|
$6.67M |
|
$6.67M |
|
$6.67M |
|
4.93M |
|
| Cash Flow Statement Financials | |
$-26.82M |
|
-- |
|
$4.26M |
|
$30.71M |
|
$8.15M |
|
$-22.56M |
|
$3.12M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.50 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-26.82M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-393.85% |
|
-393.85% |
|
-155.11% |
|
-393.85% |
|
$1.35 |
|
$-6.46 |
|
$-6.46 |
|